Physiotherapy of Axial Spondyloarthritis

计划入组 38 人 · 首次发布于 2020 年 12 月 22 日

Osteosarcopenia in Axial Spondyloarthritis

计划入组 97 人 · 首次发布于 2024 年 8 月 29 日

Microbiome and Axial Spondyloarthritis

计划入组 95 人 · 首次发布于 2021 年 1 月 19 日

Certolizumab pegol(Cimzia)

Gut-microbiome based therapeutics (Axial Therapeutics)

Vunakizumab

Axial Therapeutics, Inc.

United States

SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK

United States

Adial Pharmaceuticals

United States

TNF Inhibitors Reduce Fracture Risk in Axial Spondyloarthritis Patients

Vunakizumab Shows Sustained Efficacy in Radiographic Axial Spondyloarthritis: JAMA

Filgotinib Meets Primary Endpoint in Phase 3 Trial for Axial Spondyloarthritis